Clinical Trial Update: Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the efficacy and tolerability of rimegepant for preventing migraines in adults with inadequate response to prior prevent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Rimegepant (rimegepant)

Snippet

Sponsor: Pfizer | Conditions: Migraine | Phase 4 | Status: COMPLETED